Large-scale testing (Phase 3)Study completedNCT01190189
What this trial is testing
Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study
Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 137